Acadia Healthcare shares rise as two firms lift price targets following stronger-than-expected Q1 earnings and raised guidance.
Acadia Healthcare (NASDAQ:ACHC) surged after RBC Capital raised its price target to $31 from $28 and maintained an Outperform rating. The upgrade followed the company’s Q1 earnings beat and improved guidance, which reversed earlier declines in the stock.
Raymond James also upgraded ACHC to Strong Buy from Outperform, lifting its price target to $39 from $25. The firm cited a solid Q1 performance, a modest raise in 2026 EBITDA and earnings outlook, and expectations of rising estimates as the company targets $200M from underperforming facilities.
Shares reacted positively as investors digested management’s commentary, which walked back earlier concerns about broad-based denials and bad debt. The company operates behavioral healthcare services across the U.S.